July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Macular Changes in eyes with Alport Syndrome
Author Affiliations & Notes
  • Yasuki Ito
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Hiroshi Fukukita
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Keiko Kataoka
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Hiroki Kaneko
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Jun Takeuchi
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Hirotaka Ito
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Hiroko Terasaki
    Ophthalmology, Nagoya Univ Graduate School of Medicine, Nagoya, AICHI, Japan
  • Footnotes
    Commercial Relationships   Yasuki Ito, None; Hiroshi Fukukita, None; Keiko Kataoka, None; Hiroki Kaneko, None; Jun Takeuchi, None; Hirotaka Ito, None; Hiroko Terasaki, None
  • Footnotes
    Support  JSPS KAKENHI GRANT
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5262. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yasuki Ito, Hiroshi Fukukita, Keiko Kataoka, Hiroki Kaneko, Jun Takeuchi, Hirotaka Ito, Hiroko Terasaki; Macular Changes in eyes with Alport Syndrome. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5262.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Alport syndrome is an inherited disease characterised by renal failure, hearing loss, lenticonus and retinopathy that is caused by mutation of the type IV collagen genes. Because type IV collagen is a component of the ILM, ILM is impaired in Alport syndrome. This retrospective, cross-sectional clinical study was performed to investigate whether similar findings to postoperative changes after ILM peeling for macular holes may exist in eyes with Alport syndrome.

Methods : The medical records of 6 eyes of 3 patients with Alport syndrome (age: 30, 41 and 42 years) were reviewed. Papillofoveal distance was measured in the Spectralis® fundus image in both eyes and compared with normal control eyes. In the horizontal Spectralis® OCT images, the thicknesses of different retinal layers (total retina, inner layer, layer between outer nuclear layer and ellipsoid zone (ONL-EZ), layer between ellipsoid zone and retinal pigment epithelium (EZ-RPE)) at 1000 μm nasally and temporally to the foveal centre were measured. Superficial en face OCT images were also evaluated.

Results : The papillofoveal distance in Alport syndrome was significantly shorter than that in normal control eyes (4107.8±284.5 μm vs. 4430.5±129.7 μm, respectively; p <0.05). The thicknesses of total retina, inner layer, ONL-EZ, and EZ-RPE was 135.9±26.0, 61.5 ±15.0, 37.5 ±3.2, 36.9 ±11.2 μm at temporal side and 212.6±78.8, 130.9±54.3, 43.0±19.7, 38.8±13.8 μm at nasal side, respectively. The thicknesses of total retina, inner layer at temporal side was significantly thinner than nasal side (both p<0.05), and thicknesses of ONL-EZ and EZ-RPE were not significantly different (both p>0.05). Superficial en face images showed spindle-shaped dimples mainly in the temporal retina, which has a shape similar to that of the dimples observed after surgery with ILM peeling.

Conclusions : The shorter papillofoveal distance, horizontal retinal thickness asymmetry, and inner retinal changes mainly found in temporal area in Alport syndrome were similar to the changes after ILM peeling for the macular holes. These similarities suggest that these changes are caused by the loss of ILM. ILM may have an important role in maintaining normal retinal structure.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×